InvestorsHub Logo
Followers 1741
Posts 142040
Boards Moderated 4
Alias Born 09/11/2005

Re: HDOGTX post# 410

Saturday, 12/14/2013 10:33:56 AM

Saturday, December 14, 2013 10:33:56 AM

Post# of 19450
PAWS.0184 to close the 93 million dollar-Pharmacy-Company-REVERSE-MERGER this week... It's looks like the New company may be worth .25 to .50 per share, could be a nice REVERSE MERGER PLAY..


The PAWS Pet Company, Inc. to Acquire MESA Pharmacy of Irvine, CA

REVERSE MERGER UNDERWAY

NEWS-Mesa Pharmacy's Sales exceed $3,600,000 in November. Audit Nearly Complete.

Acquisition May Be Completed Soon
FDA Reclassification of Hydrocodone to Schedule II Could Boost Sales.

PALO ALTO, CA, Dec. 5, 2013 /PRNewswire/ - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that work on the name change to Praxsyn Corporation is nearing completion and that the Company expects to be able to file a request with FINRA early next week along with filing the necessary filings and disclosures with the SEC and the State of Illinois.

Furthermore, the audit of Mesa Pharmacy, Inc.'s (MESA) financial statements is very nearly complete and the parties believe that once the name change is effective, the parties believe that the acquisition can be closed rapidly. The parties have specified a target date on or around December 21, 2013.

Furthermore, during November 2013, MESA's sales of its non-narcotic topical pain management creams exceeded $3,600,000, however the Company believes that the recent decision by the FDA to recommend the reclassification of Hydrocodone Combination Products to Schedule II could have profoundly beneficial effects on sales of Mesa Pharmacy, Inc.'s primary products.

http://ih.advfn.com/p.php?pid=nmona&article=60278724&symbol=PAWS



Good luck..

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.